| ■ 영문 제목 : Rapid Tests Market Size, Share & Trends Analysis Report By Product (Instruments, Consumables), By Technology (Immunoassay, Molecular Diagnostics), By Application, By End-use, By Region, And Segment Forecasts, 2023 - 2030
|
 | ■ 상품코드 : GRV23MA027
■ 조사/발행회사 : Grand View Research
■ 발행일 : 2023년 1월
■ 페이지수 : 110
■ 작성언어 : 영어
■ 보고서 형태 : PDF
■ 납품 방식 : E메일 (납기:3일)
■ 조사대상 지역 : 세계
■ 산업 분야 : 의료
|
■ 판매가격 / 옵션
(부가세 10% 별도)
| Single User (1인 열람용) | USD5,950 ⇒환산￦8,032,500 | 견적의뢰/주문/질문 |
| Multi User (5인 열람용) | USD6,950 ⇒환산￦9,382,500 | 견적의뢰/주문/질문 |
| Global/corporate License (기업 열람용) | USD8,950 ⇒환산￦12,082,500 | 견적의뢰/구입/질문 |
※가격옵션 설명
- 납기는 즉일~2일소요됩니다. 3일이상 소요되는 경우는 별도표기 또는 연락드립니다.
- 지불방법은 계좌이체/무통장입금 또는 카드결제입니다.
|
미국 Grand View Research (그랜드뷰리서치)는 세계의 신속 검사 시장 규모가 2023년부터 2030년 사이에 연평균 8.6% 성장하여, 2030년에는 25억 달러에 이를 것으로 예측하고 있습니다. 본 조사 자료는 세계의 신속 검사 시장을 조사대상으로 하여, 조사 방법 및 범위, 개요, 시장 변동/동향/범위, 제품별 (기기, 소모품, 기타) 분석, 기술별 (분자 진단, 면역 측정법, 기타) 분석, 용도별 (상기도 감염증, 항생제 - 내성 감염증 (MRSA, 폐렴구균, 기타), 패혈증) 분석, 최종 용도별 (병원 및 클리닉, 연구소, 가정용 검사 및 기타) 분석, 지역별 (북미, 유럽, 아시아 태평양, 중남미, 중동/아프리카) 분석, 경쟁 현황 등의 내용을 게재하고 있습니다. 또한 본 자료는 Abbott, BD (Becton, Dickinson and Company), bioMérieux SA, DiaSorin S.p.A., Danaher Corporation, Thermo Fisher Scientific, Inc., F. Hoffmann - La Roche Ltd 등의 기업 정보가 포함되어 있습니다.
・조사 방법 및 범위
・개요
・시장 변동/동향/범위
・세계의 신속 검사 시장 규모 : 제품별
- 기기의 시장 규모
- 소모품 시장 규모
- 기타 제품의 시장 규모
・세계의 신속 검사 시장 규모 : 기술별
- 분자 진단 기술의 시장 규모
- 면역 측정법의 시장 규모
- 기타 기술의 시장 규모
・세계의 신속 검사 시장 규모 : 용도별
- 상기도 감염증에 사용되는 신속 검사의 시장 규모
- 항생제 - 내성 감염증 (MRSA, 폐렴구균, 기타)에 사용되는 신속 검사의 시장 규모
- 패혈증에 사용되는 신속 검사의 시장 규모
・세계의 신속 검사 시장 규모 : 최종 용도별
- 병원 및 클리닉에서 사용되는 신속 검사의 시장 규모
- 연구소에서 사용되는 신속 검사의 시장 규모
- 가정용 검사 및 기타 최종 용도에서 사용되는 신속 검사의 시장 규모
・세계의 신속 검사 시장 규모 : 지역별
- 북미의 신속 검사 시장 규모
- 유럽의 신속 검사 시장 규모
- 아시아 태평양의 신속 검사 시장 규모
- 중남미의 신속 검사 시장 규모
- 중동/아프리카의 신속 검사 시장 규모
・경쟁 현황
・기업 정보 |
■ 보고서 개요Rapid Tests Market Growth & Trends
The global rapid tests market size is expected to reach USD 2.50 billion by 2030, registering a CAGR of 8.6% from 2023 to 2030, according to a new report by Grand View Research, Inc. Increase in aging population, rising prevalence of target diseases, and growing demand for point of care facilities are the key factors driving the rapid diagnostics space growth. In addition, the launch of technologically advanced products is further boosting this space.
Rapid diagnostics play an important role in disease testing by rendering quick and effective results. The growing prevalence of infectious diseases like sepsis and respiratory diseases, such as tuberculosis and influenza, is expected to drive the market during the forecast period. According to WHO, tuberculosis is among the top 10 causes of death globally; about 10.0 million new cases of tuberculosis were recorded in 2021, accounting for approximately 1.4 million deaths.
Moreover, as per World Health Organization (WHO), around 50.0 million people are estimated to be affected by sepsis every year. Furthermore, the rise in drug-resistant infections is another impact-rendering driver of market growth. Therefore, the rising burden of such diseases is increasing the demand for diagnostics and fueling the rapid tests market.
The space is witnessing rapid technological advancements to obtain low-cost, improved accuracy, and highly portable products. Companies such as Roche Diagnostics and Abbott Laboratories have introduced portable products that are user-friendly and therefore can be easily adopted by patients. Moreover, innovative product launches in the market are also due to the rising number of R&D and partnership programs by industry players.
For instance, in April 2021, Chembio Diagnostics, Inc. introduced a rapid point-of-care COVID-19/Flu A&B test in the U.S. market. This product is approved for laboratory use along with a CLIA-waived license, which is suitable for differentiating between influenza and COVID-19 in a shorter turnaround time in traditional & decentralized settings.
Key market players are strategically taking initiatives such as launching novel products, facility expansions, and mergers and acquisitions, which are further driving the rapid diagnostics space growth. For instance, in July 2022, Cytovale announced 510(k) pending for its rapid sepsis risk stratification test, IntelliSep, which can produce results in 10 minutes. Moreover, in April 2022, bioMérieux announced the acquisition of Specific Diagnostics. Through this acquisition, bioMérieux is expected to gain the advantage of Specific Diagnostics’ rapid Antimicrobial Susceptibility Test (AST) system.
Rapid Tests Market Report Highlights
• By product, the consumables segment dominated the market in 2022, with a revenue share of 68.08%. Growing demand for the testing of upper respiratory diseases and commercialization of a number of PoC assays are some of the key factors driving the segment
• In 2022, immunoassay dominated the space with a 52.45% share in the technology segment. Immunoassays typically have high product penetration as they offer higher testing efficacy and accuracy. However, the molecular diagnostics segment is expected to witness the fastest growth during the forecast period
• In 2022, by application, the upper respiratory tract infections segment dominated the space, due to the increase in product approvals and high incidences of infectious diseases that affect the lungs. However, the antibiotic-resistant infections segment is expected to exhibit the fastest growth during the forecast period
• Based on end-use, hospitals and clinics are well-established segments that have contributed significantly to revenue in 2022. However, the at-home setting is a lucrative segment owing to the cost-effectiveness and comfort level of POCT provided to patients at home
• By region, North America had the highest revenue share in the global rapid tests market in 2022. However, Asia Pacific is expected to be the fastest-growing region during the forecast period
■ 보고서 목차Table of Contents
Chapter 1 Methodology And Scope
1.1 Market Segmentation And Scope
1.1.1 Segment Scope
1.1.2 Regional Scope
1.1.3 Estimates And Forecast Timeline
1.2 Research Methodology
1.3 Information Procurement
1.3.1 Purchased Database:
1.3.2 GVR’s Internal Database
1.3.3 Secondary Sources
1.3.4 Primary Research
1.3.5 Details Of Primary Research
1.4 Information Or Data Analysis
1.4.1 Data Analysis Models
1.5 Market Formulation & Validation
1.6 Model Details
1.6.1 Commodity Flow Analysis
1.6.1.1 Approach: Commodity Flow Approach
1.7 Research Assumptions
1.8 List Of Secondary Sources
1.9 List Of Abbreviations
1.10 Objectives
1.10.1 Objective 1
1.10.2 Objective 2
1.10.3 Objective 3
1.10.4 Objective 4
Chapter 2 Executive Summary
2.1 Market Outlook
Chapter 3 Rapid Tests Diagnostics Market Variables, Trends, And Scope
3.1 Market Lineage Outlook
3.1.1 Parent Market Outlook
3.2 Penetration And Growth Prospect Mapping
3.3 Regulatory And Reimbursement Framework
3.4 Market Driver Analysis
3.4.1 Increasing Adoption Of Self – Testing & Point – Of – Care Products, And Introduction Of CLIA Waived Tests
3.4.2 Growing Geriatric Population Base
3.4.3 Introduction Of Advance Technology Enabled Products
3.4.4 Growing Prevalence Of Target Diseases
3.5 Market Restraint Analysis
3.5.1 Presence Of Ambiguous Regulatory And Reimbursement Framework For Primary Care Setting
3.5.2 Rapid Tests Sensitivity And Accuracy
3.6 Industry Analysis – Porter’s
3.7 Barriers To Entry
3.8 PESTLE Analysis, By Factor (Political & Legal, Economic, And Technological)
3.9 Market Entry Strategies
Chapter 4 Rapid Tests Market: Segment Analysis, By Product, 2018 – 2030 (USD Million)
4.1 Rapid Tests Market: Product Movement Analysis
4.2 Instruments
4.2.1 Instruments Market, 2018 – 2030 (USD Million)
4.3 Consumables
4.3.1 Consumables Market, 2018 – 2030 (USD Million)
4.4 Others
4.4.1 Others Market, 2018 – 2030 (USD Million)
Chapter 5 Rapid Tests Market: Segment Analysis, By Technology, 2018 – 2030 (USD Million)
5.1 Rapid Tests Market: Technology Movement Analysis
5.2 Molecular Diagnostics
5.2.1 Molecular Diagnostics Market, 2018 – 2030 (USD Million)
5.3 Immunoassay
5.3.1 Immunoassay Market, 2018 – 2030 (USD Million)
5.4 Others
5.4.1 Others Market, 2018 – 2030 (USD Million)
Chapter 6 Rapid Tests Market: Segment Analysis, By Application Type, 2018 – 2030 (USD Million)
6.1 Rapid Tests Market: Application Type Movement Analysis
6.2 Upper Respiratory Tract Infections
6.2.1 Upper Respiratory Tract Infections Market, 2018 – 2030 (USD Million)
6.2.2 Influenza And Parainfluenza Virus
6.2.2.1 Influenza And Parainfluenza Virus Market, 2018 – 2030 (USD Million)
6.2.3 Respiratory Syncytial Virus
6.2.3.1 Respiratory Syncytial Virus Market, 2018 – 2030 (USD Million)
6.2.4 Streptococcus
6.2.4.1 Streptococcus Market, 2018 – 2030 (USD Million)
6.3 Antibiotic – Resistant Infections (MRSA, Streptococcus Pneumonia, And Others)
6.3.1 Antibiotic – Resistant Infections (MRSA, Streptococcus Pneumoniae, And Others) Market, 2018 – 2030 (USD Million)
6.4 Sepsis
6.4.1 Sepsis Market, 2018 – 2030 (USD Million)
6.4.1.1 Bacterial Sepsis
6.4.1.1.1 Bacterial Sepsis Market, 2018 – 2030 (USD Million)
6.4.1.2 Fungal Sepsis
6.4.1.2.1 Fungal Sepsis Market, 2018 – 2030 (USD Million)
6.4.1.3 Others
6.4.1.3.1 Others Market, 2018 – 2030 (USD Million)
Chapter 7 Rapid Tests Market: Segment Analysis, By End – Use, 2018 – 2030 (USD Million)
7.1 Rapid Tests Market: End – Use Movement Analysis
7.2 Hospitals & Clinics
7.2.1 Hospitals & Clinics Market, 2018 – 2030 (USD Million)
7.3 Laboratories
7.3.1 Laboratories Market, 2018 – 2030 (USD Million)
7.4 At – Home Testing And Others
7.4.1 At – Home Testing And Others Market, 2018 – 2030 (USD Million)
Chapter 8 Rapid Tests Market: Segment Analysis, By Region, 2018 – 2030 (USD Million)
8.1 Regional Market Share Analysis, 2022 & 2030
8.2 Regional Market Snapshot
8.3 Market Size, & Forecasts, Revenue And Trend Analysis, 2022 To 2030
8.4 North America
8.4.1 North America Market Estimates And Forecast, 2018 – 2030 (USD Million)
8.4.2 U.S.
8.4.2.1 U.S. Market Estimates And Forecast, 2018 – 2030 (USD Million)
8.4.3 Canada
8.4.3.1 Canada Market Estimates And Forecast, 2018 – 2030 (USD Million)
8.5 Europe
8.5.1 Europe Market Estimates And Forecast, 2018 – 2030 (USD Million)
8.5.2 Uk
8.5.2.1 Uk Market Estimates And Forecast, 2018 – 2030 (USD Million)
8.5.3. Germany
8.5.3.1 Germany Market Estimates And Forecast, 2018 – 2030 (USD Million)
8.5.4 Spain
8.5.4.1 Spain Market Estimates And Forecast, 2018 – 2030 (USD Million)
8.5.5 France
8.5.5.1 France Market Estimates And Forecast, 2018 – 2030 (USD Million)
8.5.6 Italy
8.5.6.1 Italy Market Estimates And Forecast, 2018 – 2030 (USD Million)
8.5.7 Denmark
8.5.7.1 Denmark Market Estimates And Forecast, 2018 – 2030 (USD Million)
8.5.8 Sweden
8.5.8.1 Sweden Market Estimates And Forecast, 2018 – 2030 (USD Million)
8.5.9 Norway
8.5.9.1 Norway Market Estimates And Forecast, 2018 – 2030 (USD Million)
8.6 Asia Pacific
8.6.1 Asia Pacific Market Estimates And Forecast, 2018 – 2030 (USD Million)
8.6.2 Japan
8.6.2.1 Japan Market Estimates And Forecast, 2018 – 2030 (USD Million)
8.6.3 China
8.6.3.1 China Market Estimates And Forecast, 2018 – 2030 (USD Million)
8.6.4 India
8.6.4.1 India Market Estimates And Forecast, 2018 – 2030
8.6.5 Australia
8.6.5.1 Australia Market Estimates And Forecast, 2018 – 2030
8.6.6 South Korea
8.6.6.1 South Korea Market Estimates And Forecast, 2018 – 2030
8.6.7 Thailand
8.6.7.1 Thailand Market Estimates And Forecast, 2018 – 2030
8.7 Latin America
8.7.1 Latin America Market Estimates And Forecast, 2018 – 2030 (USD Million)
8.7.2 Brazil
8.7.2.1 Brazil Market Estimates And Forecast, 2018 – 2030 (USD Million)
8.7.3 Mexico
8.7.3.1 Mexico Market Estimates And Forecast, 2018 – 2030 (USD Million)
8.7.4 Argentina
8.7.4.1 Argentina Market Estimates And Forecast, 2018 – 2030 (USD Million)
8.8 Middle East & Africa (Mea)
8.8.1 Middle East & Africa Market Estimates And Forecast, 2018 – 2030 (USD Million)
8.8.2 South Africa
8.8.2.1 South Africa market estimates and forecast, 2018 – 2030 (USD Million)
8.8.3 Saudi Arabia
8.8.6.1 Saudi Arabia market estimates and forecast, 2018 – 2030 (USD Million)
8.8.4 UAE
8.8.4.1 UAE market estimates and forecast, 2018 – 2030 (USD Million)
8.8.5 Kuwait
8.8.5.1 Kuwait market estimates and forecast, 2018 – 2030 (USD Million)
Chapter 9 Rapid tests market: Competitive Analysis
9.1 Recent Developments and Impact Analysis, by Key Market Participants
9.1.1 New Product Launches
9.1.2 Mergers and Acquisitions
9.1.3 Partnerships and Strategic Collaborations
9.1.4 Conferences and Campaigns
9.2 Company Categorization
9.2.1 Innovators
9.2.2 Market Leaders
9.3 Vendor Landscape
9.3.1 List of key distributors and channel partners
9.3.2 Key company market share analysis, 2022
9.4 Private Companies
9.4.1 List of key emerging companies
9.5 Public Companies
9.5.1 Company market position analysis
9.5.2 Competitive dashboard analysis
9.6 Company Profiles
9.6.1 Abbott
9.6.1.1 Company overview
9.6.1.2 Financial performance
9.6.1.3 Product benchmarking
9.6.1.4 Strategic initiatives
9.6.2 BD (Becton, Dickinson and Company)
9.6.2.1 Company overview
9.6.2.2 Financial performance
9.6.2.3 Product benchmarking
9.6.2.4 Strategic initiatives
9.6.3 bioMérieux SA
9.6.3.1 Company overview
9.6.3.2 Financial performance
9.6.3.3 Product benchmarking
9.6.3.4 Strategic initiatives
9.6.4 DiaSorin S.p.A.
9.6.4.1 Company overview
9.6.4.2 Financial performance
9.6.4.3 Product benchmarking
9.6.4.4 Strategic initiatives
9.6.5 Danaher Corporation
9.6.5.1 Company overview
9.6.5.2 Financial performance
9.6.5.3 Product benchmarking
9.6.5.4 Strategic initiatives
9.6.6 Thermo Fisher Scientific, Inc.
9.6.6.1 Company overview
9.6.6.2 Financial performance
9.6.6.3 Product benchmarking
9.6.6.4 Strategic initiatives
9.6.7 F. Hoffmann – La Roche Ltd
9.6.7.1 Company overview
9.6.7.2 Financial performance
9.6.7.3 Product benchmarking
9.6.7.4 Strategic initiatives
|
| ※본 조사보고서 [세계의 신속 검사 시장 (2023~2030) : 기기, 소모품] (코드 : GRV23MA027) 판매에 관한 면책사항을 반드시 확인하세요. |
| ※본 조사보고서 [세계의 신속 검사 시장 (2023~2030) : 기기, 소모품] 에 대해서 E메일 문의는 여기를 클릭하세요. |
※당 사이트에 없는 보고서도 취급 가능한 경우가 많으니 문의 주세요!
